Joint pain 21 24 mood swings and depression.
Breast cancer hormone drugs side effects.
I counsel patients every week regarding management of many of these side effects from these medications particularly the effects of these medications on desire sexual response and vaginal dryness.
Also called serms these drugs prevent breast cancer cells from binding to.
In combination with a cdk 4 6 inhibitor or pi3k inhibitor to treat metastatic breast cancer as initial hormone therapy or after other hormone treatments have been tried.
Joint and muscle pain.
Side effects of hormone therapy for breast cancer include.
There are several types of hormone therapy to treat breast cancer including.
Risk of heart attack angina heart failure and hypercholesterolemia 20 bone loss.
For more information on any of these side effects visit the treatment side effects section.
Vaginal dryness or irritation.
Joint pain arthralgia and muscle pain myalgia are common side effects of aromatase inhibitors 99 101.
These medications may have some side effects.
The table below gives you a summary of some of the most common possible side effects of the different hormonal therapy medicines so you can do a general side by side comparison.
Pdf version 135kb.
Joint and muscle pain.
If you re getting hormone therapy for breast cancer you might notice.
What are the side effects of hormone therapy.
If you re having hormone therapy for prostate cancer side effects might.
The pain may be in the hands and wrists feet and ankles knees back or other parts of the body.
Because these drugs affect hormones side effects often include symptoms associated with menopause.
Hot flashes mood swings night sweats osteoporosis vaginal discharge and vaginal dryness are.
Alone to treat advanced breast cancer after other hormone drugs like tamoxifen and often an aromatase inhibitor have stopped working.
Side effects of aromatase inhibitors aromatase inhibitors tend to cause fewer serious side effects than tamoxifen such as blood clots stroke and endometrial cancer.
Impotence in men with breast cancer.
Selective estrogen receptor modulators.